Literature DB >> 2056389

Control of differentiation in a rectal adenocarcinoma cell line: the role of diffusable and cell-associated factors.

R Del Buono1, M Pignatelli, P A Hall.   

Abstract

The rectal adenocarcinoma cell line, HRA-19a1.1, was cultured in a three-dimensional type I collagen gel and then xenografted in nu/nu mice to determine whether the in vivo environment could induce further morphological differentiation of the in vitro collagen gel cultures. Three phenotypic changes were observed. Type I collagen induces glandular differentiation in vitro in which well polarized cells are organized around a central lumen, as has been previously reported. Seven days after xenografting this structure in nu/nu mice, the glandular structures appeared to have 'ballooned' forming cyst-like structures lined by a monolayer of flattened cells. There were no stromal cells associated with the graft at this stage, but with time stromal cells invaded the collagen. At points where these cells were closely associated with the HRA-19 cells there was a marked phenotypic change, with the flattened lining cells seen at day 7 becoming columnar. By 21 days the stromal cells had replaced the collagen and the histology of the graft now resembled that of an adenocarcinoma. Placing this cell-collagen culture in a Millipore chamber prior to grafting resulted in cyst-like structures only. Here we provide conclusive evidence that heterologous connective tissue cells can induce differentiation of a rectal adenocarcinoma cell line by a non- or poorly diffusible factor(s). Furthermore, we show that this cell-collagen xenograft method has certain advantages over conventional xenograft methods: notably, a consistent 100 per cent take rate; considerably fewer cells are required to form a tumour; and the time taken to form a tumour is dramatically reduced.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056389     DOI: 10.1002/path.1711640111

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Establishment and characterisation of two cell lines derived from a primary adenocarcinoma of the duodenum.

Authors:  M Golding; G W Stamp; T Oates; E N Lalani
Journal:  Clin Mol Pathol       Date:  1996-02

Review 2.  Tumors as organs: complex tissues that interface with the entire organism.

Authors:  Mikala Egeblad; Elizabeth S Nakasone; Zena Werb
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

Review 3.  Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon.

Authors:  Ferenc Sipos; Orsolya Galamb
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

Review 4.  Dynamic interplay between the collagen scaffold and tumor evolution.

Authors:  Mikala Egeblad; Morten G Rasch; Valerie M Weaver
Journal:  Curr Opin Cell Biol       Date:  2010-09-06       Impact factor: 8.382

5.  Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells.

Authors:  S C Kirkland
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

6.  Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells.

Authors:  A P de Bruïne; W N Dinjens; E P van der Linden; M M Pijls; P T Moerkerk; F T Bosman
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

7.  Engineering a Tumor Microenvironment-Mimetic Niche for Tissue Regeneration with Xenogeneic Cancer Cells.

Authors:  Zhenzhen Wang; Chunming Wang; Ayipaxia Abudukeremu; Xiaying Rui; Shang Liu; Xiaoyi Zhang; Min Zhang; Junfeng Zhang; Lei Dong
Journal:  Adv Sci (Weinh)       Date:  2018-01-02       Impact factor: 16.806

8.  Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts.

Authors:  Benjamin Wasinski; Anjum Sohail; R Daniel Bonfil; Seongho Kim; Allen Saliganan; Lisa Polin; Mohamad Bouhamdan; Hyeong-Reh C Kim; Marco Prunotto; Rafael Fridman
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.